within Pharmacolibrary.Drugs.C_CardiovascularSystem.C10B_LipidModifyingAgentsCombinations.C10BX09_RosuvastatinAndAmlodipine;

model RosuvastatinAndAmlodipine
  extends Pharmacolibrary.Drugs.ATC.C.C10BX09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C10BX09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Rosuvastatin and amlodipine is a fixed-dose combination drug used in the management of cardiovascular diseases like hypertension and hypercholesterolemia. Rosuvastatin is a statin that lowers cholesterol, while amlodipine is a calcium channel blocker for hypertension. The fixed-dose combination (ATC code: C10BX09) is approved and used in clinical practice for adults as adjunct therapy to diet and exercise to reduce risk of cardiovascular events.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models for the fixed combination C10BX09 identified. Parameter estimates below are based on individual drug literature and standard adult population, oral administration.</p><h4>References</h4><ol><li><p>Moon, SJ, et al., &amp; Kim, MG (2019). Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects. <i>Drug design, development and therapy</i> 13 2533–2542. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S210364&quot;>10.2147/DDDT.S210364</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31440035/&quot;>https://pubmed.ncbi.nlm.nih.gov/31440035</a></p></li><li><p>Yoon, DY, et al., &amp; Chung, JY (2020). Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers. <i>Drug design, development and therapy</i> 14 661–668. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S233014&quot;>10.2147/DDDT.S233014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32109991/&quot;>https://pubmed.ncbi.nlm.nih.gov/32109991</a></p></li><li><p>Park, JS, et al., &amp; Kim, MG (2019). Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects . <i>International journal of clinical pharmacology and therapeutics</i> 57(12) 612–622. DOI:<a href=&quot;https://doi.org/10.5414/CP203554&quot;>10.5414/CP203554</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31549624/&quot;>https://pubmed.ncbi.nlm.nih.gov/31549624</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end RosuvastatinAndAmlodipine;
